Hepatic organoids for microfluidic drug screening
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
We introduce the microfluidic organoids for drug screening (MODS) platform, a digital microfluidic system that is capable of generating arrays of individually addressable, free-floating, three-dimensional hydrogel-based microtissues (or 'organoids'). Here, we focused on liver organoids, driven by the need for early-stage screening methods for hepatotoxicity that enable a "fail early, fail cheaply" strategy in drug discovery. We demonstrate that arrays of hepatic organoids can be formed from co-cultures of HepG2 and NIH-3T3 cells embedded in hydrogel matrices. The organoids exhibit fibroblast-dependent contractile behaviour, and their albumin secretion profiles and cytochrome P450 3A4 activities are better mimics of in vivo liver tissue than comparable two-dimensional cell culture systems. As proof of principle for screening, MODS was used to generate and analyze the effects of a dilution series of acetaminophen on apoptosis and necrosis. With further development, we propose that the MODS platform may be a cost-effective tool in a "fail early, fail cheaply" paradigm of drug development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Hydrogels as extracellular matrix mimics for 3D cell culture
Tibbitt, M. W., & Anseth, K. S. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22361 · Cited by 2,727
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
The role of matrix stiffness in regulating cell behavior†
Wells, R. G. (2008) · Hepatology · doi:10.1002/hep.22193 · Cited by 1,059
The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
Wrighton, S. A., & Stevens, J. C. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209145319 · Cited by 944
Inhibition and Induction of Cytochrome P450 and the Clinical Implications
Lin, J. H., & Lu, A. Y. H. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835050-00003 · Cited by 829
Gerets, H. H. J., Tilmant, K., Gerin, B., Chanteux, H., Depelchin, B. O., Dhalluin, S., & Atienzar, F. A. (2012) · Cell Biology and Toxicology · doi:10.1007/s10565-011-9208-4 · Cited by 698
Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels
Tsang, V. L., Chen, A. A., Cho, L. M., Jadin, K. D., Sah, R. L., DeLong, S., West, J. L., & Bhatia, S. N. (2007) · The FASEB Journal · doi:10.1096/fj.06-7117com · Cited by 462
A microfluidic 3D hepatocyte chip for drug toxicity testing
Toh, Y.-C., Lim, T. C., Tai, D., Xiao, G., van Noort, D., & Yu, H. (2009) · Lab on a Chip · doi:10.1039/b900912d · Cited by 419
Research works printed but not linked: 2
- Mugele, 2005, J. Phys.: Condens. Matter, 17, R705
- Fiddes, 2012, Biomicrofluidics, 6
Cited by
Items 101–162 of 162
Research progress and application of liver organoids for disease modeling and regenerative therapy
Hu, Y., Geng, Q., Wang, L., Wang, Y., Huang, C., Fan, Z., & Kong, D. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02455-3 · Cited by 21
“After over a decade of research, various orga-noid models have been successfully established, including the intestines [9, 12, 13], liver [10, 14, 15], pancreas [16, 17], lungs [18–20], stomach [21–23], esophagus [24, 25], bladder [26], kidneys [27–29], ovaries [30, 31], mammary glands [32–34],…”
BackgroundYang, H., Niu, S., Guo, M.-H., & Xue, Y. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03777-4 · Cited by 19
Jabri, A., Khan, J. A., Taftafa, B., Alsharif, M., Mhannayeh, A., Chinnappan, R., Alzhrani, A., Kazmi, S., Mir, M. S., Alsaud, A. W., et al. (2024) · Bioengineering · doi:10.3390/bioengineering11040346 · Cited by 15
“The application of an efficient digital microfluidic system has been demonstrated for drug screening and evaluation of hepatotoxicity [117].”
MethodZakhariants, A. A., Burmistrova, O., & Poloznikov, A. A. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3651-z · Cited by 16
“This fact necessitates the development of new methods for toxicity evaluation by highly informative in vitro tests based on the use of modern cell technologies [3,9].”
MethodDevelopment of In Vitro Toxicology
Singh, S., Khanna, V. K., & Pant, A. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804667-8.00001-8 · Cited by 17
Feng, Y., Wang, B., Tian, Y., Chen, H., Liu, Y., Fan, H., Wang, K., & Zhang, C. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111966 · Cited by 16
Bioinspired Engineering of Organ-on-Chip Devices
Wang, L., Li, Z., Xu, C., & Qin, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9791-2_13 · Cited by 14
Recent Advances in 3D-Cultured Brain Tissue Models Derived from Human iPSCs
Choi, N. Y., Lee, M., & Jeong, S. (2022) · BioChip Journal · doi:10.1007/s13206-022-00075-y · Cited by 14
Microfluidics for High-Throughput Quantitative Studies of Early Development
Levario, T. J., Lim, B., Shvartsman, S. Y., & Lu, H. (2016) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-100515-013926 · Cited by 16
Value of Organoids from Comparative Epithelia Models.
Schwarz, J., de Jonge, H. R., & Forrest, J. N. (2015) · PubMed Central · Cited by 20
Validating Well-Functioning Hepatic Organoids for Toxicity Evaluation
Choi, S. Y., Kim, T. H., Kim, M. J., Mun, S. J., Kim, T., Jung, K. K., Oh, I. U., Oh, J. H., Son, M. J., & Lee, J. H. (2024) · Toxics · doi:10.3390/toxics12050371 · Cited by 15
“DILI stands out as the leading cause of regulatory actions, including pharmaceutical market withdrawals [13].”
BackgroundInventions and Innovations in Preclinical Platforms for Cancer Research
Moshksayan, K., Kashaninejad, N., & Saidi, M. S. (2018) · Inventions · doi:10.3390/inventions3030043 · Cited by 13
“Digital microfluidic platforms also are used for spheroid formation and culture [121].”
MethodDigital Microfluidics: Automating Microscale Liquid Handling
Abdelgawad, M. O. (2020) · IEEE Nanotechnology Magazine · doi:10.1109/mnano.2020.2966204 · Cited by 13
“JUNE 2020 | IEEE NANOTECHNOLOGY MAGAZINE | 17 that can be implemented on a DMF device include heating and cooling [110], cell transport [92], [111], concentration [112], retention [113] and counting [114], protein precipitation [115], dissolution [34] and digestion [21], [79], liquid–liquid extraction [19], [35], f lu…”
MethodBody-on-a-Chip: Regenerative Medicine for Personalized Medicine
Skardal, A., Shupe, T. D., & Atala, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809880-6.00044-8 · Cited by 17
Liver Buds and Liver Organoids: New Tools for Liver Development, Disease and Medical Application
Zeng, F., Zhang, Y., Han, X., Weng, J., & Gao, Y. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09909-z · Cited by 13
“The changes to CYP activity were consistent with conventional 2D cultures, demonstrated the expression of CYP450 enzyme in liver organoids [91].”
BackgroundYang, Z., Yu, J. Q., & Wong, C. C. (2024) · Cells · doi:10.3390/cells13161312 · Cited by 13
“Firstly, the use of microfluidics provides dynamical and duration fashion [74,76 could minimizes cultures [80]. opportunity to reduce variability, potentially during the tedious experiment process [74,81].”
BackgroundO’Donnell, N., & Dmitriev, R. I. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67358-5_4 · Cited by 15
Modeling colorectal cancers using multidimensional organoids
Sayed, I. M., El‐Hafeez, A. A. A., Maity, P. P., Das, S., & Ghosh, P. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.02.005 · Cited by 13
Preclinical In Vitro Studies: Development and Applicability
Osakwe, O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802220-7.00006-5 · Cited by 14
Rezania, V., Coombe, D., & Tuszyński, J. A. (2020) · Journal of Functional Biomaterials · doi:10.3390/jfb11010013 · Cited by 11
“[87] based on 3D hydrogel micro-tissues and used to study hepatic co-culture systems.”
MethodLiu, J., Zhang, Y. F., & Yu, Y. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05557-w · Cited by 14
“Upon this platform, acetaminophen-mediated cell toxicity was analyzed without manual intervention [110].”
Engineering organoid microfluidic system for biomedical and health engineering: A review
Xing, Y., Liu, J., Guo, X., Liu, H., Zeng, W., Wang, Y., Zhang, C., Lu, Y., Dong, H., Ma, S., et al. (2020) · Chinese Journal of Chemical Engineering · doi:10.1016/j.cjche.2020.11.013 · Cited by 11
Liver organoids and their application in liver cancer research
Song, X., Hou, K., Zhou, H., Yang, J., Cao, T., & Zhang, J. (2023) · Regenerative Therapy · doi:10.1016/j.reth.2023.12.011 · Cited by 13
Singh, Y. P., Moses, J. C., Kim, M.-H., Gupta, D., Pal, V., Deniz, I. D., Gerhard, E. M., & Ozbolat, I. T. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.11.024 · Cited by 22
Research progress of organoids-on-chips in biomedical application
Wu, Q., Pan, Y., Wan, H., Hu, N., & Wang, P. (2019) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972018-00860 · Cited by 9
Mori, N., & Kida, Y. S. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12948 · Cited by 9
Mammalian cell culture and analysis in digital microfluidic platforms
Gümüşcü, B. (2025) · Lab on a Chip · doi:10.1039/d5lc00250h · Cited by 7
Chen, C., Chiang, T.-S., Chiou, L., Lee, M., & Lin, F. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01627h · Cited by 7
Meng, R., Yu, L., Li, X., Ning, N., Hao, H., Zhang, X., Song, W., Song, W., & Li, X. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04599-6 · Cited by 8
“…solve the respective short-comings of organoids and organ-on-a-chip, provide a more realistic model for new drug discovery, safety testing, disease diagnosis and treatment, and personalized medicine, and effectively bridge the gap between in vitro experiments and clinical applications [76–78].”
The promise and potential of liver organoids: Development, classification and application
Wang, Y., Ye, Z., Lin, Y., Zhao, Y., Zhong, D., Chen, J., Yin, J., Yan, J., & Wang, Y. (2026) · TransMed · doi:10.1016/j.tmed.2026.100003 · Cited by 9
Free-floating epithelial micro-tissue arrays: a low cost and versatile technique
Flood, P. F., Alvarez, L., & Reynaud, E. G. (2016) · Biofabrication · doi:10.1088/1758-5090/8/4/045006 · Cited by 6
Annamalai, R. T., Naik, T., Prout, H., Putnam, A. J., & Stegemann, J. P. (2018) · Biomedical Materials · doi:10.1088/1748-605x/aab66f · Cited by 8
“to fabricate high throughput in vitro drug testing assays [9].”
MethodSilvani, G., Stenzel, M. H., & Kilian, K. A. (2025) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00019 · Cited by 8
Vlieghere, E. D., de Vijver, K. K. V., Blondeel, E., Carpentier, N., Ghobeira, R., Pauwels, J., Riemann, S., Minsart, M., Fieuws, C., Mestach, J., et al. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00441-3 · Cited by 8
“Both spheroid and organoid models are used as tissue-relevant screening tools [39, 40].”
MethodOn-Chip Drug Screening Technologies for Nanopharmaceutical and Nanomedicine Applications
Önbaş, R., Bilginer-Kartal, R., & Yıldız, A. A. (2020) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-44925-4_8 · Cited by 6
Microfluidic manipulation of the multicellular spheroids and organoids for modeling human diseases
Zhao, L., Xiong, S., Wang, D., & Wang, X. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.113718 · Cited by 5
Kim, S., Baek, S. Y., & Cha, C. (2024) · ChemBioChem · doi:10.1002/cbic.202400482 · Cited by 5
Digital Microfluidics for Bioanalysis
Ruan, Q., Guo, J., Wang, Y., Zou, F., Lin, X., Wang, W., & Yang, C. J. (2019) · doi:10.1002/9783527818341.ch2 · Cited by 4
Cell Metabolite Analysis on Microfluidic Platform
Lin, X., & Lin, J. (2017) · Integrated analytical systems · doi:10.1007/978-981-10-5394-8_12 · Cited by 3
Tissue organoid models and applications
Leach, T. S., Dominijanni, A. J., Murphy, S. V., & Atala, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00085-x · Cited by 3
Delafosse, M., Regnault, E., Gebauer‐Barrett, J., Manz, A., & Sung, B. (2025) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70061 · Cited by 2
“128 This platform enabled the on-chip formation of gel components and subsequent self-organization of hepatic orga-noids (based on HepG2 and NIH-3T3 cell lines) in the gel matrix.”
Digital Microfluidics for Single Cell Manipulation and Analysis
Pang, L., Ding, J., & Fan, S. (2021) · Springer eBooks · doi:10.1007/978-981-10-8953-4_41 · Cited by 2
Ramesh, P., & Palaniappan, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29260-6.00006-8 · Cited by 1
Biopolymers for In Vitro Tissue Model Biofabrication
Skardal, A. (2016) · CRC Press eBooks · doi:10.1201/9781315368863-7 · Cited by 2
Solanas, E., Plá-Palacín, I., Sainz‐Arnal, P., de Almeida, M. B., Luè, A., Serrano, T., & Baptista, P. M. (2017) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-60511-1_2 · Cited by 1
Bioengineering of Liver Tissue
Sainz‐Arnal, P., Plá-Palacín, I., Sánchez‐Romero, N., de Almeida, M. B., Morini, S., Solanas, E., Luè, A., Serrano, T., & Baptista, P. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809880-6.00062-x · Cited by 4
Body-on-a-chip: three-dimensional engineered tissue models
Shupe, T. D., Skardal, A., & Atala, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00078-2 · Cited by 1
Tissue Engineering and Analysis in Droplet Microfluidics
Shi, N., Moniruzzaman, M., & Easley, C. J. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839162855-00223 · Cited by 4
Advances in Micro-Bioreactor Design for Organ Cell Studies
Mandenius, C. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-232-7 · Cited by 1
George, S. M. (2014) · UTA ResearchCommons (University of Texas Arlington)
Industrially Scalable Human Liver Organoids
Wu, B. T. (2015) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/vnmy-wy17
Development of Digital Microfluidics Platform for 2D and 3D Chemosensitivity Assays
Situ, H. (2017) · TSpace (University of Toronto)
Microdevices and Microsystems for Cell Manipulation
Ohta, A. T., & Hu, W. (2017) · MDPI eBooks · doi:10.3390/books978-3-03842-619-6
Steyer, D. J. (2019) · Deep Blue (University of Michigan)
Digital Microfluidics for Single Cell Manipulation and Analysis
Pang, L., Ding, J., & Fan, S. (2020) · Springer eBooks · doi:10.1007/978-981-10-4857-9_41-1
Zeng, X., Ma, Q., Li, X., You, L., Li, J., Fu, X., Ren, Y., & You, F. (2022) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2022-1027
Biomimetic injectable hydrogels of gelatin and hyaluronic acid for hepatic cell culture
Rodríguez-Fernández, J. (2024) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/207128
Microfluidics in drug screening and drug delivery
Sengar, D., Gopakumar, V., Chaudhari, B. P., & Gajbhiye, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95533-1.00007-2
Karunakara, S. H., Charmanna, S. O., Srinivasa, S., Gowda, N. G. S., Shiragannavar, V. D., Kabekkodu, S. P., & Santhekadur, P. K. (2025) · Springer eBooks · doi:10.1007/978-981-97-5742-8_4
Organoid Technology: Disease Modeling, Drug Discovery, and Personalized Medicine
Aich, J., Ballav, S., Zafar, I., Khan, A., Singh, S., Paul, M. K., Devrajan, S., & Basu, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238693125010004
Xu, H., Dai, C., Sun, S., Liu, Z., Hu, Z., Shao, C., & Wang, Z. (2026) · Applied Materials Today · doi:10.1016/j.apmt.2026.103310
Swain, S., Hameed, S. S., Jain, S., Kumar, S. S., Pati, F., Unni, H. N., Suar, M., & Giri, L. (2026) · Progress in Additive Manufacturing · doi:10.1007/s40964-026-01837-y
“With the advent of lab-on-a-chip technology, there has been a significant improvement in the design of devices for 3D culture [2, 5, 7], imaging [4], and drug screening [11, 12] using soft lithography.”
Metadata
- Authors
- Au, S. H., Chamberlain, M. D., Mahesh, S., Sefton, M. V., & Wheeler, A. R.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Wheeler, Aaron R.
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014-07-02
- Volume
- 14
- Issue
- 17
- Pages
- 3290
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2041356700
- Cited by
- 162
- References
- 50
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 16 · 2023: 11 · 2022: 9 · 2021: 16 · 2020: 21 · 2019: 17 · 2018: 12 · 2017: 15 · 2016: 17 · 2015: 7 · 2014: 3
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- liver organoids, microfluidic organoids, hepatotoxicity screening, HepG2 cells, NIH3T3 cells, co-culture, CYP3A4, albumin secretion, fibroblast contraction, acetaminophen toxicity, apoptosis, necrosis, 3D cell culture, drug discovery
- MeSH terms
- Animals, Pharmaceutical Preparations, Humans, Liver, NIH 3T3 Cells, Microfluidic Analytical Techniques, Mice, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.